Search results

India will not revive vaccine shipments until 2022

Location:

INDIA

India suspended its ‘vaccine diplomacy’ in April, choosing to prioritise shots for its own population, as it came under pressure from a massive second wave of COVID-19 infections…

India’s key vaccine challenge is at home, not abroad

Location:

INDIA

Its vaccine production capacity has increased in the intervening period to the extent that it now has a surplus of doses, even allowing for supplies abroad. A key reason why so…

India’s vaccine roll-out faces key obstacles

Location:

INDIA

Earlier this month, the Drugs Controller General of India (DCGI) approved the Oxford/AstraZeneca vaccine, marketed in India as ‘Covishield’, and a locally developed jab. The…

The EU's vaccine troubles may only be temporary

Location:

EU

Indeed, by bargaining hard with vaccine providers and opting for a more deliberate approval process, EU countries are considerably behind the United Kingdom and United States in…

India’s vaccine diplomacy brings money and influence

Location:

INDIA

Last week, its partners in the ‘Quad’ grouping -- the United States, Japan and Australia -- agreed to help increase its vaccine manufacturing and exporting capacity. Each of the…

Cuba vaccine success could open major opportunities

Location:

CUBA

The vaccine is one of four being developed by Cuba, which aims to become a key international vaccine supplier, to enhance the strategic and economic impacts of its health…

Vietnam will quicken pace of vaccine roll-out

Location:

VIETNAM

Meanwhile, its programme to vaccinate the population against the coronavirus is proceeding slowly: fewer than 160,000 of its roughly 98 million people are fully inoculated. The…

Central Asia's vaccination campaigns will be patchy

Location:

CENTRAL ASIA

Vaccination, procurement and limited local production are in train but face many systemic obstacles. One state, Turkmenistan, claims it has never had a COVID-19 case, while…

South-east Asia outbreaks bring risk and opportunity

Location:

SOUTH-EAST ASIA

In recent months, the region has received jabs manufactured in China, India and Russia -- the key practitioners of ‘vaccine diplomacy’ -- as well as shots made in the West…

Pandemic may encourage pharma policy rethink in Brazil

Location:

BRAZIL

Brazil, one of the hardest-hit countries, has a long history of policy and practice aimed at matching universal healthcare with sustainable local supply. Successful technological…